|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.624
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.541
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.380
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.317
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.263
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.240
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.221
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.182
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.178
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.155
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.155
|
|
|
endoplasmic reticulum to cytosol transport
|
GO:1903513 |
12 |
0.150
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.149
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.149
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.136
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.127
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.126
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.123
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.123
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.118
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.114
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.107
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.105
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.099
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.096
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.090
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.088
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.082
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.081
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.079
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.075
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.074
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.074
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.072
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.071
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.071
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.070
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.070
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.068
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.067
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.066
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.062
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.062
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.061
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.059
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.058
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.058
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.057
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.054
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.053
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.053
|
|
|
regulation of relaxation of muscle
|
GO:1901077 |
8 |
0.052
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.050
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.050
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.049
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.048
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.048
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.048
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.048
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.047
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.047
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.047
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.046
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.046
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.045
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.044
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.044
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.043
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.043
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.043
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.042
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.042
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.041
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.041
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.040
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.040
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.039
|
|
|
heart process
|
GO:0003015 |
94 |
0.039
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.039
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.038
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.038
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.037
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.037
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.037
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.037
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.035
|
|
|
cation transport
|
GO:0006812 |
399 |
0.035
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.035
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.035
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.035
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.035
|
|
|
response to muscle inactivity involved in regulation of muscle adaptation
|
GO:0014877 |
4 |
0.035
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.035
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.035
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.034
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.034
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.034
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.034
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.034
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.034
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.033
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.033
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.033
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.033
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.033
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.033
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.033
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.033
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.033
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.032
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.032
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.032
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.032
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.031
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.031
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.030
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.030
|
|
|
skin development
|
GO:0043588 |
220 |
0.030
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.030
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.029
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.029
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.029
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.029
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.029
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.029
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.029
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.029
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.029
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.029
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.029
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.029
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.029
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.029
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.029
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.028
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.028
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.028
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.027
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.027
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.027
|
|
|
response to muscle inactivity
|
GO:0014870 |
4 |
0.027
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.027
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.027
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.027
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.027
|
|
|
somite development
|
GO:0061053 |
81 |
0.027
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.027
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.026
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.026
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.026
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.026
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.026
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.026
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.026
|
|
|
phosphocreatine metabolic process
|
GO:0006603 |
1 |
0.026
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.026
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.026
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.025
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.025
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.025
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.025
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.025
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.025
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.024
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.024
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.024
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.024
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.024
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.023
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.023
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.023
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.023
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.023
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.023
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.023
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.023
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.023
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.023
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.023
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.023
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.023
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.023
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.023
|
|
|
skeletal muscle myosin thick filament assembly
|
GO:0030241 |
1 |
0.023
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.023
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.022
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.022
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.022
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.022
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.022
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.022
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.022
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.022
|
|
|
regulation of protein depolymerization
|
GO:1901879 |
26 |
0.022
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.022
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
regionalization
|
GO:0003002 |
337 |
0.022
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.021
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.021
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.021
|
|
|
muscle filament sliding
|
GO:0030049 |
1 |
0.021
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.021
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.021
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.021
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.021
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.021
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.021
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.021
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.020
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.020
|
|
|
segmentation
|
GO:0035282 |
93 |
0.020
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.020
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.020
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.020
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.020
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.020
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.020
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.019
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.019
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.019
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.019
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.019
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.019
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.019
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.019
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.019
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.019
|
|
|
regulation of microtubule depolymerization
|
GO:0031114 |
13 |
0.019
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.019
|
|
|
tube closure
|
GO:0060606 |
91 |
0.019
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.018
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.018
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.018
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.018
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.018
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.018
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.018
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.018
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
defecation
|
GO:0030421 |
1 |
0.018
|
|
|
tube formation
|
GO:0035148 |
140 |
0.018
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.018
|
|
|
actin myosin filament sliding
|
GO:0033275 |
1 |
0.018
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.018
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.018
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.018
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.018
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.018
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.018
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.018
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.018
|
|
|
bone development
|
GO:0060348 |
120 |
0.017
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.017
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.017
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.017
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.017
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.017
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.017
|
|
|
sinoatrial node development
|
GO:0003163 |
4 |
0.017
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.017
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.017
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.017
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.017
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.017
|
|
|
ear development
|
GO:0043583 |
200 |
0.017
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.017
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.017
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.017
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.017
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.017
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.017
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.017
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.017
|
|
|
cognition
|
GO:0050890 |
149 |
0.017
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.016
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.016
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.016
|
|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
26 |
0.016
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.016
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.016
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.016
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.016
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.016
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.016
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.016
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.016
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.016
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.016
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.016
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.016
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.015
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.015
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.015
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.015
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.015
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.015
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.015
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.015
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.015
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.015
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.015
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.015
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.015
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.015
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.015
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.015
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.015
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.015
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.015
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.015
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.015
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.015
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.015
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.015
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.014
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.014
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.014
|
|
|
rna processing
|
GO:0006396 |
105 |
0.014
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.014
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.014
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.014
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.014
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.014
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.014
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.014
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.014
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.014
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.014
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.014
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.014
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.014
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.014
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.014
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.014
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.014
|
|
|
organ growth
|
GO:0035265 |
117 |
0.014
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.014
|
|
|
detection of yeast
|
GO:0001879 |
2 |
0.014
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.014
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.014
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.014
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.013
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.013
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.013
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.013
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.013
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.013
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.013
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.013
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.013
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.013
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.013
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.013
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.013
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.013
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.013
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.013
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.013
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.013
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.013
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.013
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.013
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.013
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.013
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.013
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.013
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.013
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.012
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.012
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.012
|
|
|
protein localization to cell junction
|
GO:1902414 |
3 |
0.012
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.012
|
|
|
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
GO:0010881 |
7 |
0.012
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.012
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.012
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.012
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.012
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.012
|
|
|
midgut development
|
GO:0007494 |
4 |
0.012
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.012
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.012
|
|
|
rna interference
|
GO:0016246 |
2 |
0.012
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.012
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.012
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.012
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.012
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
fertilization
|
GO:0009566 |
127 |
0.012
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.012
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.012
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.012
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.012
|
|
|
pallium development
|
GO:0021543 |
120 |
0.012
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.012
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.012
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.012
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.012
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.012
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.012
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.012
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.012
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.012
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.012
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.012
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.012
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.012
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.012
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.012
|
|
|
cell division
|
GO:0051301 |
120 |
0.012
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.012
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.011
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
36 |
0.011
|
|
|
response to heat
|
GO:0009408 |
27 |
0.011
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.011
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.011
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.011
|
|
|
cellular amino acid biosynthetic process
|
GO:0008652 |
22 |
0.011
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.011
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.011
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.011
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.011
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.011
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.011
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.011
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.011
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.011
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.011
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.011
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.011
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.011
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.011
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.011
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.011
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.011
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.011
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.011
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.011
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.011
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.011
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.011
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.011
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.011
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.011
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.011
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.011
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.011
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.011
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.011
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.011
|
|
|
palate development
|
GO:0060021 |
76 |
0.011
|
|
|
tricuspid valve development
|
GO:0003175 |
3 |
0.011
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.011
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.011
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.011
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.011
|
|
|
histone modification
|
GO:0016570 |
159 |
0.011
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.011
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.011
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.011
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.011
|
|
|
response to uv a
|
GO:0070141 |
1 |
0.011
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.010
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.010
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.010
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.010
|
|